OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
Pan Lai, Yang Wang
Cancer Biology and Medicine (2021) Vol. 18, Iss. 1, pp. 34-51
Open Access | Times Cited: 16

Showing 16 citing articles:

Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, A Roggo, Egle Ramelyte, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 885-894
Closed Access | Times Cited: 2

Targeting the Epigenome Reduces Keloid Fibroblast Cell Proliferation, Migration and Invasion
Nedaa Almier, Kassidy Leibowitz, Adam C. Gower, et al.
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 2

Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation
Zsuzsanna Gaál
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5838-5838
Open Access | Times Cited: 10

Emerging drugs for the treatment of cutaneous T-cell lymphoma
Melissa Cheng, Jasmine Zain, Steven T. Rosen, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 1, pp. 45-54
Open Access | Times Cited: 9

Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes
Esperanza Montaner-Angoiti, Pablo Jesús Marín‐García, Lola Llobat
Animals (2023) Vol. 13, Iss. 3, pp. 468-468
Open Access | Times Cited: 5

Epigenetics and Cutaneous Neoplasms: From Mechanism to Therapy
Frederick Gibson, Ailish Hanly, Robert Fisher, et al.
Epigenomics (2023) Vol. 15, Iss. 3, pp. 167-187
Closed Access | Times Cited: 5

Predictive biomarkers in lymphoma: a systematic research review
Román Rolando Lima Cajas, Gabriela Fernanda Panchi Espin, Robert Adan Lalama Rueda, et al.
Ibero-American Journal of Health Science Research (2024) Vol. 4, Iss. s, pp. 47-56
Open Access | Times Cited: 1

Epigenetic modulation of the tumor immune microenvironment by nanoinducers to potentiate cancer immunotherapy
Ning Zhang, Xishan Hao
Cancer Biology and Medicine (2021) Vol. 18, Iss. -
Open Access | Times Cited: 7

Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma
Monaza Adeeb, Lubna Therachiyil, Safwan Moton, et al.
International review of cell and molecular biology (2023), pp. 149-171
Closed Access | Times Cited: 2

New and emerging therapies in cutaneous T-cell lymphoma
Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, et al.
Dermatology Reports (2024)
Open Access

MicroRNAs And Long Non-Coding RNAs In T-Cell Lymphoma: Mechanisms, Pathway, Therapeutic Opportunities
Mohammed H. Abu-Alghayth, Adil Abalkhail, Ali Hazazi, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155769-155769
Closed Access

PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations
Shunfeng Hu, Tiange Lu, Juanjuan Shang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 1

Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma
Xiaotong Xue, Zhenzhen Wang, Zihao Mi, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 2

Updates on Molecular Pathogenesis of Non-Hodgkin’s Lymphoma
Hassan Abolhassani
(2023), pp. 201-214
Closed Access

Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma
Mitchell N. Lefebvre, Nicholas Borcherding, Ryan J. Reis, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access

DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
Eliza Mari Kwesi‐Maliepaard, Muddassir Malik, Tibor van Welsem, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access

Page 1

Scroll to top